May 31, 2026
From gains to brain games
Creatine raise brain energy levels and slow Alzheimer's cognitive decline by 30%
Gym powder may be helping brains too — and the comments instantly turned into dosage debates, side-effect confessions, and AI article suspicion
TLDR: Early research says creatine, the popular workout supplement, may boost brain energy and slow early Alzheimer’s decline by 30%. Commenters swung from excited “I can feel it working” stories to dosage detective work, side-effect warnings, and suspicion that the article itself was AI-written.
The internet has officially discovered that creatine isn’t just for getting bigger arms. A review and early trial suggest the wildly common gym supplement may help the brain run on more energy and could even slow early Alzheimer’s decline by 30% — and the comment section reacted like someone had dropped pre-workout into a medical conference.
One camp was instantly smug in the most lovable way possible: people already taking creatine said, basically, “I knew it!” One commenter claimed it’s one of the only supplements they actually feel when they stop, which gave the whole thread a strong bro-science redemption arc vibe. Then the practical crowd stormed in. One user dropped a direct study link and immediately went hunting for dosage details, noting studies ranged from 5 grams a day to 20–25 grams, while reminding everyone that 5 grams is the usual daily amount. Classic internet move: exciting headline, instant spreadsheet energy.
But of course, not everyone was ready to crown creatine the new miracle brain dust. One commenter said even tiny amounts make them tired and foggy, which threw some real-life messiness into the hype. And then came the final twist: a skeptical reader accused the article itself of being AI-generated, shifting the drama from health claims to “can we trust what we’re reading?” So yes, the science got attention — but the real show was the comments, where hope, caution, and side-eye all started lifting together.
Key Points
- •The article says creatine supplementation may raise phosphocreatine levels in neurons after crossing the blood-brain barrier.
- •The article cites a 2025 review and a pilot trial as the main sources for reported brain-related creatine findings.
- •According to the article, the cited findings span cognitive performance, depression outcomes, sleep-deprivation resilience, and early Alzheimer’s disease.
- •The article reports a 30% slowing of cognitive decline in early Alzheimer’s patients in controlled trials.
- •The article explains creatine’s proposed brain effects through its role in phosphocreatine metabolism and ATP regeneration.